Drugs / cinepazide
cinepazide
also known as
cinepazide maleate · Cinepazida · MD 67350 FREE BASE · Methanesulfonic acid cinepazide injection
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01851759 | Oct 2013 → Aug 2014 | ischemic stroke | Xijing Hospital | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT04951232 | Jul 2016 → Jan 2017 | ischemic stroke | Peking University Third Hospital | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01831011 Comparator | Jul 2008 → Apr 2010 | ischemic stroke | Xijing Hospital | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cinepazide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01851759 ↗ |
| Known as | Cinepazida | ChEMBL registry synonym — accepted as the source's own label CHEMBL1874750 ↗ |
| Known as | cinepazide maleate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01831011 ↗ |
| Known as | MD 67350 FREE BASE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1874750 ↗ |
| Known as | Methanesulfonic acid cinepazide injection | “Methanesulfonic acid cinepazide injection” NCT01851759 ↗ |
| Modality | Small molecule | — CHEMBL1874750 ↗ |
| Route | Intravenous | “iv gtt” NCT01851759 ↗ |